Login / Signup

Prevalence and trends of polypharmacy in U.S. adults, 1999-2018.

Xiaowen WangKeyang LiuKokoro ShiraiChengyao TangYonghua HuYing WangYuantao HaoJia-Yi Dong
Published in: Global health research and policy (2023)
From 1999-2000 to 2017-2018, the prevalence of polypharmacy is continually increasing in U.S. adults. The polypharmacy was especially higher in the older, in patients with heart disease, or diabetes. The high prevalence urges the healthcare providers and health policymakers to manage polypharmacy among specific population groups.
Keyphrases
  • healthcare
  • risk factors
  • adverse drug
  • public health
  • cardiovascular disease
  • mental health
  • pulmonary hypertension
  • emergency department
  • skeletal muscle
  • climate change
  • electronic health record